***********************************
Brakke Consultingの
Animal Health News & Notes for October 14, 2016
Copyright © Brakke Consulting, Inc.
編集者: リン・フォンドン DVM MBA
************************************
ニュース:
Brakke Consulting ニュース
2017 Pet Pharmaceutical Market Shift Study – early order discount extended
OTCチャネル
収益ニュース
ビルバック
その他のニュース
ベントレーのペット用品
Boehringer Ingelheim (divestiture)
Boehringer Ingelheim (Ultra Duramune Lyme)
チェヴァ
ダイヤモンドペットフーズ
EI メディカルイメージング
Gimborn Holding
イミュセル
メルク
メリアル
Moochie & Co
Tサイトセラピューティクス
***********************************
株式会社ブラッケコンサルティング
2016-2017 ペット医薬品市場シフト調査
EARLY-ORDER DISCOUNT EXTENDED ONE WEEK – DEADLINE OCTOBER 21
Brakke Consulting と Trone Brand Energy は、近々実施されるペット医薬品市場シフト調査を発表できることを嬉しく思います。2015 年に完了した最初の調査では、ペットの飼い主が動物病院以外で自由に処方薬を購入したいという要望を明らかにしました。約 25% のクリニックが購入行動の変化によりすでに収益の減少を経験しており、薬剤師の大多数は市場の需要によりペット用医薬品の調剤を増やす必要があると考えていました。
2017 年の追加調査では、顧客の購買意欲を維持するために獣医師が何をすべきかを特定します。また、獣医師が製造業者や販売業者が人間の薬局やインターネットに直接販売することに対する態度や反応を測定するとともに、獣医師が顧客との信頼関係を維持できるように製造業者や販売業者がどのような行動を取ることができるかを調べます。
この調査は2017年初頭に完了する予定です。詳細については、David Goodnight（830-285-1259）または dgoodnight@brakkeconsulting.com.
***********************************
企業業績発表
• Virbac SA reported results for the third quarter of 2016. Consolidated sales in the third quarter amounted to EUR 216 million ($242 million), an increase of 1% compared to the same period of 2015. (+2% at constant exchange rates). (company website)
**********************************
企業ニュースリリース
• Boehringer Ingelheim, Merial and Ceva Santé Animale announced that Boehringer Ingelheim and Ceva have entered into a binding put option agreement according to which Ceva will purchase certain assets of Merial’s portfolio in the context of Boehringer Ingelheim’s business swap with Sanofi. Ceva will acquire certain animal health vaccines and pharmaceuticals from the Merial portfolio for swine, bovine and companion animals as well as related intellectual property, manufacturing processes and R&D activities. The package contains the following brands: Circovac (excluding US), Progressis, Mucosiffa, Parvovax, Parvoruvax, Equioxx (excluding US), Genixine, Ketofen 1% injection and tablets (excluding Canada) and Ketofen 10% injection (excluding Canada). (company press release)
• Merck Animal Health announced that the USDA has approved a license for Nobivac Canine Flu Bivalent vaccine. According to the company it is the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. (company press release)
• Boehringer Ingelheim Vetmedica Inc. (BIVI) announced the launch of Ultra Duramune Lyme, a new low-volume 0.5 mL vaccine for subcutaneous vaccination of healthy dogs 9 weeks of age or older as an aid in the prevention of disease caused by Borrelia burgdorferi. (company website)
• ImmuCell Corporation announced that it has broken ground on construction of its new $20 million pharmaceutical facility to produce Nisin, the active ingredient in Mast Out. The two-story facility in Portland, Maine, will provide over 16,800 square feet of fermentation, processing, laboratory and warehouse space. (company press release)
• T-Cyte Therapeutics, Inc., announced the US launch of Lymphocyte T-Cell Immunomodulator (LTCI) as the first USDA-approved treatment option for canine osteoarthritis. LTCI is administered by veterinarians via a subcutaneous injection. (Marketwired.com)
• Diamond Pet Foods announced it has entered the veterinary channel with the introduction of Diamond Care Rx Renal Formula for adult dogs. The diet is available exclusively at veterinary clinics. Diamond also launched four other Diamond Care pet food formulas that are sold at pet stores nationwide. (Veterinary Practice News)
• E.I. Medical Imaging announced the release of EVOStream, a wireless technology that allows users to view live ultrasound images on mobile devices. (Digitaljournal.com)
• Penta Investments announced it has sold Gimborn Holding GmbH to Hillhouse Capital Management, a long-term equities investor with significant investments in Asia. According to the company’s CEO, under Hillhouse management Gimborn can accelerate its planned expansion into Asia. Financial terms were not disclosed. (PETS International)
• Natural pet food retailer Bentley’s Pet Stuff has merged with Moochie & Co., an 11-store mall-based pet supply store chain in Ohio, Indiana and Kentucky. Financial terms were not disclosed. (Pet Business)
***********************************
動物の健康ニュース
• US – BOVINE VACCINE Researchers at Kansas State University have developed a new vaccine as an antibiotic-free method to prevent the transmission of Fusobacterium necrophorum in sheep and cattle to meat consumers. The vaccine uses a two-pronged approach to immunize livestock against leukotoxins produced by F. necrophorum. (AVMA Smartbrief – Healio)
• US – CANINE CANCER TEST North Carolina State University’s College of Veterinary Medicine has filed a patent application with the U.S. Patent and Trademark Office for a DNA test for canine transitional cell carcinoma. (Wraltechwire.com)
• US – THERAPY DOGS The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $79,000 grant to the University of Tennessee College of Veterinary Medicine for a new study, “The Effect of Animal-Assisted Intervention on Preoperative Anxiety and Dose of Sedation in Children.” The goal of the three-year, cross-over-designed study is to determine if interaction with a therapy dog 20 minutes prior to surgery has a significant effect on reducing a child’s anxiety levels and, in turn, lowering the dose of medication necessary for sedation. (PRWeb.com)
************************************
株式会社ブラッケコンサルティング
店頭市場を理解する
御社が新しいビジネスチャンスのためにOTCチャネルを検討している場合でも、長年OTCチャネルで流通している場合でも、Brakke Consultingのチームは、OTC流通チャネルの詳細についてさらに知りたい企業に重要かつ質の高い支援を提供できます。OTCチャネル、そこで見られる傾向、存在する機会について有意義な洞察をお探しの場合は、ダラスオフィスまたはJoel Adamsonまでお問い合わせください。 jadamson@brakkeconsulting.com.
ブラッケコンサルティング
************************************
BRAKKEコンサルティングの視点
It appears with a second divestiture of some Merial assets that the Boehringer and Merial merger is approaching completion as planned. There were other announcements this week related to animal health or pet product assets changing hands. Currently, several companies are aggressively expanding investment in the vaccine area. Prevention versus therapy is increasing in importance in health programs because of both economics and concerns over antibiotic usage. Early stage companies and universities with new platform vaccine technologies or vaccines will find a high level of interest at manufacturer, distributor and veterinary level. There also appears to be a fair amount of repositioning by a number of companies to adjust to competitive consolidations.
As for myself I have just arrived in South Dakota to assist in the annual ring neck pheasant harvest that begins this weekend. It is also a good time to check out the crops and attitudes of producers in my home state. Have a great weekend!
ロン・ブラッケ
**********************************
この電子ニュースレターは、Brakke Consulting, Inc. の独占所有物です。
ここに記載されている内容の使用は、Brakke Consulting, Inc. の承認を得て、Brakke Consulting, Inc. に適切に帰属させる必要があります。
Brakke Consultingのサービスとシンジケート調査の詳細については、当社のウェブサイトをご覧ください。 ホームページ.
ブラッケコンサルティング株式会社
12005 フォード ロード、スイート 530
ダラス、テキサス州 75234 米国
Japanese 
English 
Portuguese 
Chinese